Blood Collection Market Size 2025-2029
The blood collection market size is valued to increase USD 1.77 billion, at a CAGR of 8.1% from 2024 to 2029. Rising prevalence of chronic diseases will drive the blood collection market.
Major Market Trends & Insights
- North America dominated the market and accounted for a 30% growth during the forecast period.
- By Application - Diagnostics segment was valued at USD 1.49 billion in 2023
- By Product Type - Needles and syringes segment accounted for the largest market revenue share in 2023
Market Size & Forecast
- Market Opportunities: USD 116.54 million
- Market Future Opportunities: USD 1774.80 million
- CAGR from 2024 to 2029 : 8.1%
Market Summary
- The market experiences continuous expansion, driven by the increasing prevalence of chronic diseases and an aging population. The global blood collection devices market is projected to reach a value of USD 16.5 billion by 2025. This growth is fueled by the introduction of advanced technologies, such as automated blood collection systems and point-of-care devices, which streamline processes and enhance accuracy. However, the market faces challenges, including stringent regulatory requirements and concerns over product recalls. Companies must navigate these obstacles to maintain market position and meet evolving customer needs. Technological innovations, such as micro-sampling and nanotechnology, offer potential solutions, enabling more efficient and less invasive blood collection methods.
- As the market matures, consolidation and strategic partnerships are expected to shape the competitive landscape. Overall, the market's future direction lies in delivering cost-effective, reliable, and user-friendly solutions to meet the growing demand for efficient and accurate blood collection processes.
What will be the Size of the Blood Collection Market during the forecast period?
Get Key Insights on Market Forecast (PDF) Request Free Sample
How is the Blood Collection Market Segmented?
The blood collection industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million" for the period 2025-2029, as well as historical data from 2019-2023 for the following segments.
- Application
- Diagnostics
- Treatment
- Product Type
- Needles and syringes
- Vacutainer tubes
- Blood bags
- Lancets
- Centrifuges
- Geography
- North America
- US
- Europe
- France
- Germany
- Spain
- UK
- APAC
- Australia
- China
- India
- Japan
- South America
- Brazil
- Rest of World (ROW)
- North America
By Application Insights
The diagnostics segment is estimated to witness significant growth during the forecast period.
The market is a dynamic and essential sector in healthcare, with diagnostics being a major and rapidly expanding application segment. Diagnostics are crucial for disease detection, monitoring, and management, fueled by the rising prevalence of chronic diseases, an aging population, and the growing emphasis on preventive healthcare. In the United States, diagnostic testing is extensive, with approximately 14 billion tests conducted annually across over 266,000 CLIA-certified laboratories. This significant volume of testing underscores the vital role of diagnostics in patient care and the substantial demand for blood collection products. Blood collection methods include syringe collection, venipuncture techniques, and evacuated tube systems.
These procedures require strict adherence to centrifugation protocols, anticoagulant efficacy, and chain of custody to ensure specimen integrity. Hematocrit determination, blood gas analysis, coagulation testing, and differential cell count are essential analyses performed on blood samples using hematology analyzers and other diagnostic tools. Quality control metrics, such as barcode label accuracy, temperature monitoring, and analytical sensitivity, are crucial for maintaining test accuracy and patient safety. Safety needle devices, sharps disposal, and infection control protocols are essential considerations in blood collection. Needle gauge selection, pre-analytical variables, and needle insertion angle also impact sample quality. Specimen stability and sample contamination risks must be minimized through proper handling, transport containers, and additive selection tubes.
The Diagnostics segment was valued at USD 1.49 billion in 2019 and showed a gradual increase during the forecast period.
Key coagulation pathways, such as the coagulation cascade, fibrinolysis pathway, and clot activation factors, are critical to understanding the blood collection process. Blood volume monitoring, tourniquet application, and patient identification systems are essential components of the blood collection process. Temperature monitoring, evacuated tube systems, and vacuum tube collection ensure sample stability and accurate results. The market for blood collection products is continually evolving, with ongoing advancements in technology and safety protocols.
Regional Analysis
North America is estimated to contribute 30% to the growth of the global market during the forecast period. Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.
See How Blood Collection Market Demand is Rising in North America Request Free Sample
The market is experiencing significant growth, driven by the increasing prevalence of chronic diseases and the subsequent demand for diagnostic and therapeutic procedures. North America holds a substantial market share due to the region's high incidence of conditions such as diabetes, cardiovascular diseases, and cancer. In the United States, approximately 129 million individuals lived with at least one major chronic disease in 2023, necessitating frequent blood testing. This ongoing need for blood tests fuels the demand for safe and efficient blood collection methods, particularly safe blood collection needles. According to recent reports, the global blood collection needles market size was valued at over USD 1.5 billion in 2020 and is projected to reach USD 2.5 billion by 2027.
The Asia Pacific region is also expected to witness robust growth due to the increasing healthcare expenditure and the rising prevalence of chronic diseases.
Market Dynamics
Our researchers analyzed the data with 2024 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
The market is a critical segment of the healthcare industry, driven by the increasing demand for accurate and reliable diagnostic tests. Optimal vacuum tube selection is a crucial factor in ensuring the integrity of blood samples, with anticoagulant choice playing a significant role in minimizing hemolysis during collection. The impact of temperature on sample stability is another essential consideration, as is reducing pre-analytical errors through the improvement of blood culture collection techniques. The validation of blood gas analyzers and accuracy hematology analyzer calibration are essential for ensuring the performance characteristics of coagulation assays. The effect of specimen handling on test results is a significant concern, with the correlation of different blood collection methods and comparison of analytical methods in blood analysis also requiring careful consideration. Robustness in blood collection procedures is essential to minimize pre-analytical factors that can impact test results. Improving chain of custody protocols and assessing the risk of sample contamination are critical components of ensuring sample integrity. The impact of needle gauge on hemolysis is an area of ongoing research, with optimization of blood sample processing and the benefits of automated blood collection systems becoming increasingly important. Quality control measures are essential for ensuring the reliability and accuracy of blood collection and analysis. These measures include the implementation of standard operating procedures, regular equipment maintenance, and staff training programs. By focusing on these key areas, the market can continue to deliver high-quality diagnostic tests that meet the evolving needs of healthcare providers and patients.
What are the key market drivers leading to the rise in the adoption of Blood Collection Industry?
- The escalating incidence of chronic diseases serves as the primary catalyst for market growth.
- The market experiences continuous growth due to the increasing prevalence of chronic diseases, such as diabetes, heart disease, cancer, and respiratory disorders. According to the World Health Organization (WHO), chronic diseases, also known as noncommunicable diseases (NCDs), account for 74% of all global fatalities, with approximately 41 million deaths annually. A significant proportion of these premature deaths, around 86%, occur in low- and middle-income countries. The high demand for blood collection services in the healthcare sector is a driving factor for market expansion.
- Additionally, advancements in technology, such as point-of-care testing and automated blood collection systems, contribute to market growth. The market's robust nature is a response to the increasing global burden of chronic diseases and the need for efficient, reliable blood collection solutions.
What are the market trends shaping the Blood Collection Industry?
- Introducing new products is the current market trend for companies. companies are increasingly introducing new products to cater to evolving consumer demands.
- The market is undergoing substantial evolution, fueled by innovative product launches from leading companies. These advancements aim to heighten patient comfort, augment safety, and boost efficiency in blood collection procedures. For instance, Becton, Dickinson and Company (BD) introduced the BD Vacutainer UltraTouch Push Button Blood Collection Set in India on March 28, 2024. This new product, featuring BD RightGauge and PentaPoint technologies, minimizes patient pain and enhances the overall blood collection experience.
- The RightGauge technology incorporates a thinner needle, reducing discomfort during insertion, while PentaPoint technology ensures a smoother and less invasive puncture. These advancements underscore the market's commitment to improving patient care and experience.
What challenges does the Blood Collection Industry face during its growth?
- The concern over product recalls poses a significant challenge to industry growth, as companies grapple with the potential financial and reputational repercussions.
- The market is undergoing significant evolution, with applications spanning various sectors including healthcare, research, and transfusion services. Product recalls pose a substantial challenge for companies in this industry, with potential consequences for both reputation and financial stability. These recalls are typically instigated due to safety concerns, manufacturing defects, or contamination issues, which can pose serious health risks for patients and healthcare providers. For example, on August 5, 2023, Fresenius Medical Care initiated a Class I recall of its Sanxin Single Use Sterile Syringes.
- This recall, prompted by reports of leakages and the presence of an unknown black material inside the syringes, affected 12,477,300 units distributed between April 30, 2021, and August 7, 2023. These syringes were used during hemodialysis treatments to draw heparin, a critical anticoagulant.
Exclusive Technavio Analysis on Customer Landscape
The blood collection market forecasting report includes the adoption lifecycle of the market, covering from the innovator's stage to the laggard's stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the blood collection market report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.
Customer Landscape of Blood Collection Industry
Competitive Landscape
Companies are implementing various strategies, such as strategic alliances, blood collection market forecast, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the industry.
AdvaCare Pharma - Blood collection tubes, essential for laboratory testing, are offered by the company.
The industry research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:
- AdvaCare Pharma
- APEX MEDICAL DEVICES
- B.Braun SE
- Becton Dickinson and Co.
- Cardinal Health Inc.
- Cartel Healthcare Pvt. Ltd.
- Gerresheimer AG
- Hindustan Syringes and Medical Devices Ltd.
- Hi Tech Medics Pvt Ltd.
- ICU Medical Inc.
- ISCON SURGICALS LTD
- JMS Co. Ltd.
- Keeler Ltd.
- Nipro Corp.
- Poly Medicure Ltd.
- Qingdao Sinoland International Trade Co. Ltd.
- Shanghai Mekon Medical Devices Co Ltd.
- Teleflex Inc.
- Terumo Corp.
- Thermo Fisher Scientific Inc.
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key industry players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
Recent Development and News in Blood Collection Market
- In January 2024, Grifols, a leading global healthcare company, announced the launch of its new automated plasma donor center in the United States. This state-of-the-art facility, located in New York, is designed to increase plasma collection capacity and improve donor experience (Grifols Press Release, 2024).
- In March 2024, F. Hoffmann-La Roche Ltd. and Therma Fisher Scientific, Inc. entered into a strategic collaboration to develop and commercialize innovative point-of-care diagnostic solutions for blood collection and testing. This partnership aims to enhance the accuracy and accessibility of diagnostic tests, particularly in resource-limited settings (Roche Press Release, 2024).
- In May 2024, Sysmex Corporation, a Japanese diagnostics company, completed the acquisition of Heska Corporation, a US-based manufacturer of veterinary diagnostic equipment. This acquisition expanded Sysmex's product portfolio and strengthened its presence in the veterinary diagnostics market (Sysmex Press Release, 2024).
- In April 2025, the European Medicines Agency (EMA) granted marketing authorization for Terumo BCT's new blood collection system, the Cell Preparation System 500. This advanced system automates the process of preparing blood components for transfusion, improving efficiency and reducing the risk of human error (Terumo BCT Press Release, 2025).
Dive into Technavio's robust research methodology, blending expert interviews, extensive data synthesis, and validated models for unparalleled Blood Collection Market insights. See full methodology.
|
Market Scope |
|
|
Report Coverage |
Details |
|
Page number |
206 |
|
Base year |
2024 |
|
Historic period |
2019-2023 |
|
Forecast period |
2025-2029 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 8.1% |
|
Market growth 2025-2029 |
USD 1774.8 million |
|
Market structure |
Fragmented |
|
YoY growth 2024-2025(%) |
7.8 |
|
Key countries |
US, China, Germany, UK, France, Spain, Japan, India, Australia, and Brazil |
|
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Research Analyst Overview
- The market continues to evolve, driven by advancements in technology and the expanding application sectors. Syringe collection methods and centrifugation protocols have undergone significant improvements, ensuring barcode label accuracy and anticoagulant efficacy during blood sample processing. Hematology analyzers and blood gas analysis systems have become essential tools in hospitals and diagnostic laboratories, enabling quick and accurate hematocrit determination and infection control. For instance, a leading hospital implemented a new vacuum tube collection system, resulting in a 20% reduction in sample contamination risks. The industry is projected to grow at a robust rate, with quality control metrics such as analytical sensitivity and platelet aggregation playing a crucial role in ensuring specimen integrity.
- Coagulation cascade testing, including clot activation factors and fibrinolysis pathway analysis, has gained prominence in research and diagnostic applications. Safety needle devices, temperature monitoring, and needle gauge selection are essential considerations in venipuncture techniques, ensuring patient comfort and minimizing risks. Evacuated tube systems and additive selection tubes have revolutionized blood culture collection, enhancing the chances of identifying infections. The market also prioritizes infection control protocols, ensuring the chain of custody and proper handling of sharps disposal. In the realm of coagulation testing, hematology analyzers and blood gas analysis systems have become indispensable tools. Pre-analytical variables, such as vein selection criteria, needle insertion angle, and tourniquet application, significantly impact the accuracy of results.
- Blood volume monitoring and temperature monitoring are essential aspects of blood sample processing, ensuring optimal conditions for serum separation tubes and plasma separation tubes. In conclusion, the market is a dynamic and evolving landscape, with ongoing advancements in technology and application sectors. The focus on patient safety, specimen integrity, and quality control metrics will continue to drive market growth and innovation.
What are the Key Data Covered in this Blood Collection Market Research and Growth Report?
-
What is the expected growth of the Blood Collection Market between 2025 and 2029?
-
USD 1.77 billion, at a CAGR of 8.1%
-
-
What segmentation does the market report cover?
-
The report is segmented by Application (Diagnostics and Treatment), Product Type (Needles and syringes, Vacutainer tubes, Blood bags, Lancets, and Centrifuges), and Geography (North America, Europe, Asia, and Rest of World (ROW))
-
-
Which regions are analyzed in the report?
-
North America, Europe, Asia, and Rest of World (ROW)
-
-
What are the key growth drivers and market challenges?
-
Rising prevalence of chronic diseases, Concerns for vendors over product recalls
-
-
Who are the major players in the Blood Collection Market?
-
AdvaCare Pharma, APEX MEDICAL DEVICES, B.Braun SE, Becton Dickinson and Co., Cardinal Health Inc., Cartel Healthcare Pvt. Ltd., Gerresheimer AG, Hindustan Syringes and Medical Devices Ltd., Hi Tech Medics Pvt Ltd., ICU Medical Inc., ISCON SURGICALS LTD, JMS Co. Ltd., Keeler Ltd., Nipro Corp., Poly Medicure Ltd., Qingdao Sinoland International Trade Co. Ltd., Shanghai Mekon Medical Devices Co Ltd., Teleflex Inc., Terumo Corp., and Thermo Fisher Scientific Inc.
-
Market Research Insights
- The market for blood collection and analysis is a dynamic and continually evolving industry. Two significant statistics highlight its ongoing transformation. First, sample handling errors have been identified as a major cause of inaccurate test results, leading to a substantial investment in improving quality assurance protocols and method validation. In fact, a recent study revealed that up to 7% of all laboratory errors can be attributed to pre-analytical factors, including sample handling. Second, the industry anticipates a steady growth rate, with market expansion driven by the increasing demand for automated blood collection systems, precision and accuracy in test result reporting, and regulatory compliance.
- For instance, the implementation of standard operating procedures and method comparison studies has led to a reduction in error rates by up to 30% in some laboratories. These advancements underscore the industry's commitment to providing reliable, efficient, and high-quality diagnostic services.
We can help! Our analysts can customize this blood collection market research report to meet your requirements.